We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$830M
AUM Growth
+$70.8M
Cap. Flow
+$31.3M
Cap. Flow %
3.77%
Top 10 Hldgs %
42.39%
Holding
84
New
4
Increased
26
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$28.2M
2
AMD icon
Advanced Micro Devices
AMD
+$25.5M
3
MCK icon
McKesson
MCK
+$21.9M
4
TER icon
Teradyne
TER
+$19M
5
INTU icon
Intuit
INTU
+$16.9M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$19.5M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.3M
3
MU icon
Micron Technology
MU
+$17M
4
AVGO icon
Broadcom
AVGO
+$17M
5
BABA icon
Alibaba
BABA
+$15.1M

Sector Composition

Rank Sector Weight
1 Technology 32.99%
2 Consumer Discretionary 16.28%
3 Healthcare 14.61%
4 Financials 12.87%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MASI
51
DELISTED
Masimo
MASI
$1.19M 0.14%
8,052
-50
-0.6% -$7.57K
ABT icon
52
Abbott
ABT
$180B
$1.15M 0.14%
8,583
+100
+1% +$13.1K
SYK icon
53
Stryker
SYK
$127B
$1.12M 0.13%
3,018
– –
AWK icon
54
American Water Works
AWK
$26.3B
$989K 0.12%
7,108
– –
AZN icon
55
AstraZeneca
AZN
$263B
$892K 0.11%
5,813
– –
ATO icon
56
Atmos Energy
ATO
$29.9B
$881K 0.11%
5,160
-200
-4% -$32.3K
ADP icon
57
Automatic Data Processing
ADP
$100B
$848K 0.1%
2,888
– –
STE icon
58
Steris
STE
$20.9B
$809K 0.1%
3,270
-50
-2% -$12K
SHW icon
59
Sherwin-Williams
SHW
$78.3B
$753K 0.09%
2,175
– –
BLD
60
DELISTED
TopBuild
BLD
$684K 0.08%
1,751
+17
+1% +$6.79K
GILD icon
61
Gilead Sciences
GILD
$161B
$681K 0.08%
6,133
+64
+1% +$7.28K
NBIX icon
62
Neurocrine Biosciences
NBIX
$17.7B
$669K 0.08%
4,767
+100
+2% +$13.6K
RGA icon
63
Reinsurance Group of America
RGA
$15.7B
$637K 0.08%
3,316
-100
-3% -$19.1K
GIS icon
64
General Mills
GIS
$19.2B
$595K 0.07%
11,800
– –
CI icon
65
Cigna
CI
$76.6B
$507K 0.06%
1,760
– –
ECL icon
66
Ecolab
ECL
$75.6B
$507K 0.06%
1,850
-100
-5% -$27.2K
VLTO icon
67
Veralto
VLTO
$22.6B
$451K 0.05%
4,226
-149
-3% -$15.7K
FSLR icon
68
First Solar
FSLR
$21.8B
$441K 0.05%
2,000
– –
HD icon
69
Home Depot
HD
$332B
$405K 0.05%
999
-540
-35% -$212K
LIN icon
70
Linde
LIN
$237B
$390K 0.05%
820
– –
NEE icon
71
NextEra Energy
NEE
$187B
$340K 0.04%
4,500
– –
LPLA icon
72
LPL Financial
LPLA
$26.3B
$333K 0.04%
1,000
– –
JNJ icon
73
Johnson & Johnson
JNJ
$635B
$247K 0.03%
1,333
– –
UNP icon
74
Union Pacific
UNP
$183B
$228K 0.03%
964
– –
BAC icon
75
Bank of America
BAC
$435B
$219K 0.03%
4,248
– –
1 2
3
4

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q3 2025 Portfolio in Review

As of Q3 2025, De Burlo Group held 84 positions worth $830M, up 9.3% from $759M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

De Burlo Group deployed $31.3M of net new capital in Q3 2025, opening 4 new positions and adding to 26 existing holdings. Its largest new stake was Novo Nordisk: 481,160 shares worth $26.7M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $18.3M trimmed.

  • De Burlo Group's largest Q3 2025 buy was Novo Nordisk: 481,160 shares worth $26.7M.
  • De Burlo Group added most to Advanced Micro Devices in Q3 2025, an estimated $25.5M increase.
  • De Burlo Group's biggest Q3 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $18.3M.
  • De Burlo Group fully exited Intuitive Surgical in Q3 2025, selling an estimated $19.5M.
  • De Burlo Group's ten largest holdings make up 42% of its $830M portfolio in Q3 2025.
  • De Burlo Group opened 4 new positions and closed 6 in Q3 2025.
  • De Burlo Group's portfolio value rose 9.3% quarter-over-quarter to $830M.

Based on De Burlo Group's 13F filing for Q3 2025, filed 13 Nov 2025.